2020

• Aug.Strategic Investment by ST Pharm and 2 other Pharmaceutical Companies
  
• Apr.ATB-301, R&D Grant (Ministry of Trade, Industry and Energy)
  
• Feb.Series A Round with Stonebridge Ventures
  
• Jan.Inno-biz Certified (Technology and Innovation-Oriented SMEs)

2019

• Dec.Series A Round with Mega Investment & UTC Investment
  
• Nov.Immuno-oncology R&D Grant (Medical Innovation Foundation)
  
• Oct.Investment Agreement with Aju Pharm & KODIT
  
• Sep.Expansion & New Location of Pankyo R&D Center
  
• Jun.ATB-101, “K-Startup” R&D Grant (Ministry of SMEs and Startups)
  
• May.TASO CMO Agreement with ST Pharm
  
• Apr.ATB-301, Selected in “Pharm Navi” Project by MFDS (such as “Fast Track” regulation system in US FDA)
  
• Jan.ATB-101, Tech Transfer and Investment Agreement with Jeil Pharm.
  

2018

• Sep.Pankyo R&D Center Establishment
  
• Aug.Angel Investment
  
• Jul.Investment Agreement with TIPS
  
• ATB-301, R&D Grant (Ministry of SMEs and Startups)
  
• Feb.Venture Designation (Korea Technology Finance Corporation)
  
• Jan.Company Name Change (Autotelic Korea → Autotelic Bio)
  

2017

• Sep.ATB-101, R&D Grant (Ministry of SMEs and Startups)
  
• Corporate R&D Center Accreditation

2015

• Nov.Autotelic Korea Establishment